Clear cell/endometrioid type ovarian carcinoma associated with endometriosis of the ipsilateral ovary

In: Vojnosanitetski pregled · 2017 · vol. 76(5) , pp. 547–551 · doi:10.2298/vsp170424107r · W2756760006
article OA: gold CC0
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-09 ⓘ

This case report describes a rare instance of simultaneous clear cell/endometrioid ovarian carcinoma and endometriosis in the same ovary of a 47-year-old patient, who was successfully treated with surgery and chemotherapy.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-09-01 · read from full text ⓘ

This case report describes a 47-year-old patient who underwent surgery for a right ovarian endometriotic cyst, which was found to harbor simultaneous clear cell and endometrioid ovarian carcinoma. The treatment involved total hysterectomy with bilateral salpingo-oophorectomy, lymphadenectomy, omentectomy, and six cycles of postoperative chemotherapy using the Taxol-CBDCA protocol. Post-treatment imaging showed no disease recurrence, and the patient remained well six months after completing therapy, supporting the conclusion that early-stage detection leads to a favorable prognosis. This paper is centrally about endometriosis — specifically its association with the development of ipsilateral clear cell and endometrioid ovarian carcinomas.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Introduction. Ovarian endometriosis has been identified as a risk factor for occurrence of endometriosis-associated ovarian carcinoma. We presented a rare case of simultaneous clear cell/ endometrioid ovarian carcinoma and endometriosis of the ipsilateral ovary. Case report. A 47-yearold patient underwent surgery for right ovarian endometriotic cyst. A total hysterectomy with bilateral salpingooophorectomy, lymphadenectomy in the right psoas muscle region and omentectomy were performed as well as multiple peritoneal biopsies. Six cycles of chemotherapy were instituted postoperatively using the Taxol-CBDCA protocol. Abdominal and pelvic CT did not demonstrate recurrence of the disease postoperatively and after completed chemotherapy treatment. Six months after the completion of treatment, the patient felt well without the disease recurrence. Conclusion. Clear cell and endometrioid subtypes of ovarian carcinoma have good prognosis if they are diagnosed and treated at an early stage of the disease. In our patient, the carcinoma was detected in the first stage and successfully treated with combination therapy, i.e., surgical and chemotherapy.
Full text 2,137 characters · extracted from oa-doi-fallback · click to expand
Vojnosanitetski pregled 2019 Volume 76, Issue 5, Pages: 547-551 Clear cell/endometrioid type ovarian carcinoma associated with endometriosis of the ipsilateral ovary Rudić-Biljić-Erski Ivana (Clinic of Gynecology and Obstetrics “Narodni Front”, Belgrade, Serbia) Introduction. Ovarian endometriosis has been identified as a risk factor for occurrence of endometriosis-associated ovarian carcinoma. We presented a rare case of simultaneous clear cell/ endometrioid ovarian carcinoma and endometriosis of the ipsilateral ovary. Case report. A 47-yearold patient underwent surgery for right ovarian endometriotic cyst. A total hysterectomy with bilateral salpingooophorectomy, lymphadenectomy in the right psoas muscle region and omentectomy were performed as well as multiple peritoneal biopsies. Six cycles of chemotherapy were instituted postoperatively using the Taxol-CBDCA protocol. Abdominal and pelvic CT did not demonstrate recurrence of the disease postoperatively and after completed chemotherapy treatment. Six months after the completion of treatment, the patient felt well without the disease recurrence. Conclusion. Clear cell and endometrioid subtypes of ovarian carcinoma have good prognosis if they are diagnosed and treated at an early stage of the disease. In our patient, the carcinoma was detected in the first stage and successfully treated with combination therapy, i.e., surgical and chemotherapy. Keywords: adenocarcinoma, clear cell, diagnosis, endometriosis, ovarian neoplasms, treatment outcome https://doi.org/10.2298/VSP170424107R Full text ( 536 KB) Vasiljević Mladenko (Clinic of Gynecology and Obstetrics “Narodni Front”, Belgrade, Serbia + University of Belgrade, Faculty of Medicine, Belgrade, Serbia) Rakić Snežana (Clinic of Gynecology and Obstetrics “Narodni Front”, Belgrade, Serbia + University of Belgrade, Faculty of Medicine, Belgrade, Serbia) Džatić-Smiljković Olivera (Clinic of Gynecology and Obstetrics “Narodni Front”, Belgrade, Serbia + University of Belgrade, Faculty of Medicine, Belgrade, Serbia) Mihajlović Slađana (Clinic of Gynecology and Obstetrics “Narodni Front”, Belgrade, Serbia)

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (14)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK